FDA refreshed its Quality Management System Regulation FAQ page on November 5. One answer removes a protection device makers leaned on for decades.

Section 820.180(c) of the old quality system regulation kept management review reports, quality audit reports and supplier audit reports out of an investigator's hands. FDA now says those exceptions are not maintained in the QMSR. Investigators may also review quality system records created before February 2, 2026, when the rule took effect. FDA suggests a comparative analysis showing older records meet QMSR requirements.

The same answers confirm QSIT was withdrawn on February 2, 2026. Inspections run on Compliance Program 7382.850 instead. An ISO 13485 certificate does not exempt a manufacturer from an FDA inspection, and FDA does not work to the MDSAP audit plan. MDSAP stays voluntary. Read-only access to the standard is available through ANSI's incorporated by reference site and the ISO Online Browsing Platform.

For a first regulatory hire, the internal audit file has stopped being a private record and become an inspection artifact. Candor about an open nonconformity now reads differently when an investigator can ask for the report.